SLC5A2 and bacterial urinary tract infection: The results were largely the same as in the analysis of the entire patient population, apart from the duration of diabetes, which in this case, presented statistical significance, showing that there is a link between the duration of disease and the likelihood of contracting a UTI when taking SGLT2 inhibitors.